| Chronic fatigue syndrome–a clinically empirical approach to its definition and study WC Reeves, D Wagner, R Nisenbaum, JF Jones, B Gurbaxani, ... BMC medicine 3, 1-9, 2005 | 372 | 2005 |
| Pharmacokinetics, pharmacodynamics and physiologically-based pharmacokinetic modelling of monoclonal antibodies M Dostalek, I Gardner, BM Gurbaxani, RH Rose, M Chetty Clinical pharmacokinetics 52, 83-124, 2013 | 241 | 2013 |
| Optimization of codon pair use within the (GGGGS) 3 linker sequence results in enhanced protein expression R Trinh, B Gurbaxani, SL Morrison, M Seyfzadeh Molecular immunology 40 (10), 717-722, 2004 | 174 | 2004 |
| Combinations of single nucleotide polymorphisms in neuroendocrine effector and receptor genes predict chronic fatigue syndrome BN Goertzel, C Pennachin, L de Souza Coelho, B Gurbaxani, ... Future Medicine Ltd 7 (3), 475-483, 2006 | 160 | 2006 |
| Attenuated morning salivary cortisol concentrations in a population-based study of persons with chronic fatigue syndrome and well controls UM Nater, E Maloney, RS Boneva, BM Gurbaxani, JM Lin, JF Jones, ... The Journal of Clinical Endocrinology & Metabolism 93 (3), 703-709, 2008 | 151 | 2008 |
| Inclusion of the glucocorticoid receptor in a hypothalamic pituitary adrenal axis model reveals bistability S Gupta, E Aslakson, BM Gurbaxani, SD Vernon Theoretical Biology and Medical Modelling 4, 1-12, 2007 | 146 | 2007 |
| Factors associated with cloth face covering use among adults during the COVID-19 pandemic—United States, April and May 2020 KA Fisher MMWR. Morbidity and mortality weekly report 69, 2020 | 134 | 2020 |
| Analysis of a family of antibodies with different half-lives in mice fails to find a correlation between affinity for FcRn and serum half-life B Gurbaxani, LLD Cruz, K Chintalacharuvu, SL Morrison Molecular immunology 43 (9), 1462-1473, 2006 | 113 | 2006 |
| Functional Genomics of Serotonin Receptor 2A (HTR2A): Interaction of Polymorphism, Methylation, Expression and Disease Association VR Falkenberg, BM Gurbaxani, ER Unger, MS Rajeevan Neuromolecular medicine 13, 66-76, 2011 | 101 | 2011 |
| Chronic fatigue syndrome and high allostatic load EM Maloney, BM Gurbaxani, JF Jones, L de Souza Coelho, C Pennachin, ... Future Medicine Ltd 7 (3), 467-473, 2006 | 74 | 2006 |
| Using machine learning and an ensemble of methods to predict kidney transplant survival E Mark, D Goldsman, B Gurbaxani, P Keskinocak, J Sokol PloS one 14 (1), e0209068, 2019 | 71 | 2019 |
| Allostatic load is associated with symptoms in chronic fatigue syndrome patients BN Goertzel, C Pennachin, L de Souza Coelho, EM Maloney, JF Jones, ... Future Medicine Ltd 7 (3), 485-494, 2006 | 64 | 2006 |
| Perception versus polysomnographic assessment of sleep in CFS and non-fatigued control subjects: results from a population-based study M Majer, JF Jones, ER Unger, LS Youngblood, MJ Decker, B Gurbaxani, ... BMC neurology 7, 1-9, 2007 | 63 | 2007 |
| Theory-based behavioral predictors of self-reported use of face coverings in public settings during the COVID-19 pandemic in the United States JP Barile, RJ Guerin, KA Fisher, LH Tian, AH Okun, KL Vanden Esschert, ... Annals of Behavioral Medicine 55 (1), 82-88, 2021 | 57 | 2021 |
| Are endosomal trafficking parameters better targets for improving mAb pharmacokinetics than FcRn binding affinity? B Gurbaxani, M Dostalek, I Gardner Molecular immunology 56 (4), 660-674, 2013 | 53 | 2013 |
| Development and evaluation of multiplexed immunoassay for detection of antibodies to HPV vaccine types G Panicker, I Rajbhandari, BM Gurbaxani, TD Querec, ER Unger Journal of immunological methods 417, 107-114, 2015 | 47 | 2015 |
| Development of new models for the analysis of Fc–FcRn interactions BM Gurbaxani, SL Morrison Molecular immunology 43 (9), 1379-1389, 2006 | 41 | 2006 |
| Multi-site clinical assessment of myalgic encephalomyelitis/chronic fatigue syndrome (MCAM): design and implementation of a prospective/retrospective rolling cohort study ER Unger, JMS Lin, H Tian, BH Natelson, G Lange, D Vu, M Blate, ... American journal of epidemiology 185 (8), 617-626, 2017 | 40 | 2017 |
| Multiscale analysis of heart rate variability in non-stationary environments J Gao, BM Gurbaxani, J Hu, KJ Heilman, VA Emanuele II, GF Lewis, ... Frontiers in Physiology 4, 119, 2013 | 33 | 2013 |
| Benchmarking currently available SELDI‐TOF MS preprocessing techniques VA Emanuele, BM Gurbaxani Proteomics 9 (7), 1754-1762, 2009 | 25 | 2009 |
Suzanne D. Vernon, PhDResearch Director, Bateman Horne CenterVerified email at batemanhornecenter.org
